论文部分内容阅读
《关于城镇医药卫生体制改革的指导意见》提出了对医院药品收入进行“医药分开核算分别管理”制度,这个制度的实施对于有效控制医药费用的上涨会产生良好的效果,但如果把“医药分开核算分别管理”作为控制医药费用的惟一手段,不可能达到预期效果,甚至会造成药品支出的失控。作者从药品费用上涨的原因、控制药品费用环节以及实施“医药分开核算分别管理”制度应注意的问题等几个方面进行了思考,提出政府应从宏观上采取措施对药厂、经销商、医院三方面进行控制的观点,并指出医院在进行“医药分开核算分别管理”后应加强对医生的监控,继续发挥控制药费的关键作用。
The Guiding Opinions on the Reform of the Urban Medical and Health System puts forward the system of “differentiated medical accounting separately” for hospital drug income. The implementation of this system will have a good effect on effectively controlling the rise in medical expenses, but if it separates “Calculation separately management” as the only means to control medical expenses, can not achieve the desired results, and even cause the drug out of control. The author pondered on the reasons for the rise in drug costs, the control of drug costs, and the issues that need to be addressed in the implementation of the “Distributive Medical Accounting Separate Management” system, and suggested that the government should take measures from a macro point of view to pharmaceutical companies, distributors, and hospitals. The point of view of control, and pointed out that the hospital should strengthen the monitoring of doctors after the “different medical accounting separately management”, continue to play a key role in controlling drug costs.